[Translate to Englisch:] LAVANOX Wundsprühgel

LAVANOX-Serag® wound spray gel (Hydrogel)

LAVANOX-Serag® wound spray gel is a hydrogel in an innovative dosage form for use as a spray. it is based on water with <0.06% sodium hypochlorite as preservative. LAVANOX-Serag® wound spray gel is quick and easy to apply and remains in the wound as the hydrogel.

LAVANOX-Serag® hydrogel keeps the wound moist for long periods and does not require subsequent irrigation with any other solution. LAVANOX-Serag® wound spray gel causes no irritation and minimal pain.

Special advantages

  • Effective against bacteria, viruses and fungi 1
  • Suitable for use against Pseudomonas and MrSa 1,5
  • Reduces biofilm and deposits 1,2
  • Eliminates wound odours 2,5
  • No restriction on duration of use 3
  • Excellent tissue tolerability 1
  • No further irrigation required 3
  • No development of resistance 1,3


LAVANOX-Serag® wound spray gel is used to clean and moisten acute and chronic wounds and supports autolytic wound débridement. Hydrogels are extremely suitable for moistening wounds and for use on preservative inlays and dressings. Thanks to their effective cleansing, they promote the physiological conditions required for wound healing.

Method of use

Before using the gel for the first time and at every dressing change, clean the wound thoroughly with LAVANOX-Serag® wound irrigation solution or LAVANOX-Serag® wound spray. Shake the bottle of LAVANOX-Serag® wound spray gel well before use and apply directly to the wound by spraying several times in rapid succession. Immediately after it has been sprayed on, the solution solidifies to form a well-adhering hydrogel. LAVANOX-Serag® wound spray gel can be used in combination with gauze compresses, adhesive plasters and other dressing materials. There are no restrictions on the frequency or duration of use.

Innovative dosage form: Hydrogel for use as a spray

Innovative Darreichungsform: LAVANOX-Serag<sup>®</sup> Hydrogel zum Sprühen
Innovative Darreichungsform: LAVANOX-Serag® Hydrogel zum Sprühen
Nach der Anwendung: LAVANOX-Serag<sup>®</sup> verfestigt sich zu einem gut anhaftendem Hydrogel
Nach der Anwendung: LAVANOX-Serag® verfestigt sich zu einem gut anhaftendem Hydrogel

Shelf life

After opening: 12 weeks
Unopened: 2 years from date of manufacture


Water, <0.06% sodium hypochlorite (electrochemically activated mineral salt solution), lithium magnesium sodium silicate

Production and stability

Simplified diagram of a bacterium after the application of LAVANOX-Serag®

Sodium hypochlorite

Sodium hypochlorite (NaOCl) is an oxidising agent that splits off and releases oxygen (O). This free oxygen damages bacterial, viral and fungal cell membranes and increases their permeability. The membrane can no longer withstand the osmotic pressure and the microorganism is inactivated.1,3,4 After oxygen is split off from the sodium hypochlorite, the substance reverts to its natural state of water and salt.4 Sodium hypochlorite is also produced naturally in the body by lysosomes to defend against micro-organisms and is an important part of phagocytosis in the body’s immune defence mechanisms. But the concentration of "active chlorine" produced is so low that human tissues are not damaged.3

ECA technology

Electrochemical activation (ECA) involves passing an aqueous mineral salt solution through several electrolysis cells. ECA technology represents the further development and optimisation of membrane electrolysis for use in the  eld of medicine.
The solutions have particular physicochemical and catalytic properties and are well-established in the decontamination and irrigation of wounds and in keeping wounds moist.
Stable and very well-tolerated solutions are produced from natural starting materials such as water and mineral salts.

LAVANOX® wound spray gel/wound gel (hydrogel) Package leaflet
Art.Nr. PIP-code Quantity PU
01707311869882Plastic bottle Sprühgel 75 ml1Order
01707516043833Tube 50g1Order


1 Brill FHH. Data on file. 2013
2 Kammerlander G, Assadian O, Eberlein T, Zweitmuller P, Luchsinger S, Andriessen A. A clinical evaluation of the efficacy and safety of singlet oxygen in cleansing and disinfecting stagnating wounds. J Wound Care. 2011 Apr;20(4):149-50
3 Kramer A. Wundantiseptik. ARS MEDICI. 2016 (9): 419-426
4 Lorberth J, Massa W. Zu den chemischen Grundlagen der Wirkung von Steralythen. Wund Management 2012 (3): 52-54
5 Möller A, Splieth B, Schmitz M, Eberlein T. Produkte auf Basis elektrochemischer Aktivierung (ECA) im erweiterten medizinischen Einsatz. Medizin & Praxis. 2016 (in Druck)

© SERAG-WIESSNER GmbH & Co. KG Zum Kugelfang 8-12 95119 Naila Germany Telefon: +49 (0) 9282 937-0